The developing role of theranostics in NETs

Lancet. 2024 Jun 29;403(10446):2759-2761. doi: 10.1016/S0140-6736(24)00851-1. Epub 2024 Jun 5.

Authors

Robert A Ramirez¹, Cathy Eng²

Affiliations

¹ Division of Hematology and Oncology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. Electronic address: robert.ramirez@vumc.org.
² Division of Hematology and Oncology, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.

PMID: 38851204
DOI: 10.1016/S0140-6736(24)00851-1

No abstract available

Publication types

Comment

MeSH terms

Humans
Theranostic Nanomedicine* / methods